EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GSH‐Responsive Nanoparticles Enhance Hepatocellular Carcinoma Immunotherapy Through Synergistic Effects of Cuproptosis and PI3K Inhibitor Combination

Lei Wu, Jintong Na, Xiyu Liu, Dongsheng Tang, Zhungang Yang, Zheng Cao, Xinyue He, Haihua Xiao, Liping Zhong, Yuan Liao, Yongxiang Zhao iD

Advanced Science · 2026

DOI: 10.1002/advs.202506051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Lei Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Targeting Oncology, National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Bio-ta…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Nanoparticles, Phosphoinositide-3 Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, an emerging form of programmed cell death, is capable of inducing mitochondrial dysfunction. Moreover, the PI3K‐AKT‐mTOR signaling pathway contributes to tumor cell progression by reprogramming mitochondrial morphology and function. In this study, we have designed copper complex nanoparticles (NP Cu ) and PI3K‐AKT‐mTOR inhibitor Alpelisib nanoparticles (NP ALP ) that enhance the efficacy of cuproptosis‐based therapies. NP Cu triggers mitochondrial dysfunction and promotes the aggregation of lipoylated dihydrolipoamide S‐acetyltransferase (DLAT), while NP ALP inhibits the PI3K‐AKT‐mTOR signaling pathway to induce apoptosis. The combination of these two nanoparticles (NP Cu +NP ALP ) effectively activates the antitumor responses in the tumor microenvironment (TME). When combined with an anti‐programmed cell death protein 1 antibody (α‐PD‐1), NP Cu +NP ALP significantly inhibits tumor progression and activates antitumor immunity, offering a promising strategy for liver cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularNanoparticlesPhosphoinositide-3 Kinase InhibitorsImmunotherapyGlutathioneCuproptosisAnimalsHumansMiceSignal TransductionTumor Microenvironment

Stichwörter der Autor:innen

PI3K‐AKT‐mTORcuproptosisliver cancer

Substanzen

Phosphoinositide-3 Kinase InhibitorsGlutathione

Autor:innen und Institutionen

  • State Key Laboratory of Targeting Oncology, National Center for International Research of Biotargeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tu…
  • Targeting Theranostics Research Center of Guangxi Higher Education, Guangxi Medical University, Nanning, Guangxi, P. R. China.
  • Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, P. R. China.
  • University of Chinese Academy of Sciences, Beijing, P. R. China.
  • Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, California, USA.

ORCID-Profile: Yongxiang Zhao

Förderung

  • Guangxi Science and Technology Program

Zitieren

APA

Wu, L., Na, J., Liu, X., Tang, D., Yang, Z., Cao, Z., He, X., Xiao, H., Zhong, L., Liao, Y., & Zhao, Y. (2026). GSH‐Responsive Nanoparticles Enhance Hepatocellular Carcinoma Immunotherapy Through Synergistic Effects of Cuproptosis and PI3K Inhibitor Combination. Advanced Science. https://doi.org/10.1002/advs.202506051

Vancouver

Wu L, Na J, Liu X, Tang D, Yang Z, Cao Z, et al. GSH‐Responsive Nanoparticles Enhance Hepatocellular Carcinoma Immunotherapy Through Synergistic Effects of Cuproptosis and PI3K Inhibitor Combination. Advanced Science. 2026. doi:10.1002/advs.202506051

BibTeX
@article{Wu2026,
  author = {Wu, Lei and Na, Jintong and Liu, Xiyu and Tang, Dongsheng and Yang, Zhungang and Cao, Zheng and He, Xinyue and Xiao, Haihua and Zhong, Liping and Liao, Yuan and Zhao, Yongxiang},
  title = {GSH‐Responsive Nanoparticles Enhance Hepatocellular Carcinoma Immunotherapy Through Synergistic Effects of Cuproptosis and PI3K Inhibitor Combination},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202506051}
}
Kostenlos starten →